These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 8033955

  • 1. The association between rifamycin-SV (R-SV) related hyperbilirubinaemia and antipyrine clearance as a new test of liver function in cirrhosis.
    Persico M, Romano M, Villano N, Montella F, Gentile S.
    Eur J Clin Invest; 1994 Mar; 24(3):201-4. PubMed ID: 8033955
    [Abstract] [Full Text] [Related]

  • 2. Antipyrine clearance in comparison to conventional liver function tests in hepatitis C virus patients.
    Mahmoud M, Abdel-Kader R, Hassanein M, Saleh S, Botros S.
    Eur J Pharmacol; 2007 Aug 27; 569(3):222-7. PubMed ID: 17628532
    [Abstract] [Full Text] [Related]

  • 3. A comparison between antipyrine and aminopyrine blood clearances.
    Kawasaki S, Imamura H, Kokudo N, Bandai Y, Sanjo K, Idezuki Y.
    Hepatogastroenterology; 1992 Aug 27; 39(4):344-6. PubMed ID: 1427580
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of quantitative methods to assess hepatic function: Pugh's classification, indocyanine green, antipyrine, and dextromethorphan.
    Figg WD, Dukes GE, Lesesne HR, Carson SW, Songer SS, Pritchard JF, Hermann DJ, Powell JR, Hak LJ.
    Pharmacotherapy; 1995 Aug 27; 15(6):693-700. PubMed ID: 8602375
    [Abstract] [Full Text] [Related]

  • 8. [Endogenous bile acids in the blood as a functional test in chronic liver diseases. I. Comparison with the antipyrine elimination test].
    Habior A.
    Pol Arch Med Wewn; 1982 Aug 27; 68(3):125-32. PubMed ID: 7170227
    [No Abstract] [Full Text] [Related]

  • 9. Sites of competition in the selective hepatic uptake of rifamycin-SV, flavaspidic acid, bilirubin, and bromsulphthalein.
    Kenwright S, Levi AJ.
    Gut; 1974 Mar 27; 15(3):220-6. PubMed ID: 4842968
    [Abstract] [Full Text] [Related]

  • 10. Liver blood flow, antipyrine clearance, and antipyrine metabolite formation clearance in patients with chronic active hepatitis and alcoholic cirrhosis.
    Bauer LA, O'Sullivan T, Reiss WG, Horn JR, Opheim K, Strandness DE, Carithers RL.
    Br J Clin Pharmacol; 1994 Apr 27; 37(4):375-81. PubMed ID: 8018459
    [Abstract] [Full Text] [Related]

  • 11. Estimation of functional liver reserve in patients before cardiac surgery using antipyrine plasma clearance test.
    Takeda M, Furuse A, Kawauchi M, Kotsuka Y, Takamoto S.
    J Cardiovasc Surg (Torino); 1999 Dec 27; 40(6):817-23. PubMed ID: 10776711
    [Abstract] [Full Text] [Related]

  • 12. [Evaluation of antipyrine clearance in chronic liver diseases].
    Wang JL, Zhang F, Yuan SY.
    Zhonghua Nei Ke Za Zhi; 1989 May 27; 28(5):295-7, 315-6. PubMed ID: 2553353
    [Abstract] [Full Text] [Related]

  • 13. Alfentanil-induced miosis as a surrogate measure of alfentanil pharmacokinetics in patients with mild and moderate liver cirrhosis.
    Baririan N, Van Obbergh L, Desager JP, Verbeeck RK, Wallemacq P, Starkel P, Horsmans Y.
    Clin Pharmacokinet; 2007 May 27; 46(3):261-70. PubMed ID: 17328584
    [Abstract] [Full Text] [Related]

  • 14. Hepatic drug clearance in chronic liver disease: can we expect to find a universal, quantitative marker of hepatic function?
    Morgan DV, Smallwood RA.
    Hepatology; 1989 Nov 27; 10(5):893-5. PubMed ID: 2807171
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Antipyrine clearance in liver resections].
    Fiorentini MT, Fracchia M, Biondi AM, Capussotti L, De La Pierre M, Molino G.
    Minerva Dietol Gastroenterol; 1990 Nov 27; 36(4):209-13. PubMed ID: 2089284
    [Abstract] [Full Text] [Related]

  • 17. Saliva and plasma clearance of antipyrine as reflectors of liver function.
    Luoma PV, Sotaniemi EA.
    Eur J Drug Metab Pharmacokinet; 1981 Nov 27; 6(4):261-4. PubMed ID: 7333326
    [Abstract] [Full Text] [Related]

  • 18. Hepatic clearances of antipyrine, indocyanine green, and galactose in normal subjects and in patients with chronic liver diseases.
    Kawasaki S, Sugiyama Y, Iga T, Hanano M, Beppu T, Sugiura M, Sanjo K, Idezuki Y.
    Clin Pharmacol Ther; 1988 Aug 27; 44(2):217-24. PubMed ID: 3396264
    [Abstract] [Full Text] [Related]

  • 19. Fractional clearance of bromosulfonephthalein and metabolic clearance of antipyrine. Correlative study in liver diseases.
    Couet C, Brissot P, Messner M, Delamaire D, Gie S, Bourel M.
    Ann Gastroenterol Hepatol (Paris); 1984 Aug 27; 20(1):1-6. PubMed ID: 6529154
    [Abstract] [Full Text] [Related]

  • 20. Clinical utility of quantitative assessment of liver haemodynamics in cirrhosis provided by dynamic hepatoscintigraphy.
    Hartleb M, Kloc T, Becker A, Mańczyk I, Bołdys H.
    Acta Med Hung; 1984 Aug 27; 49(1-2):17-28. PubMed ID: 1296183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.